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Abstract
Background: Unambiguous interpretation of ordered rating scale response categories requires distinct meanings of 
category labels. Also, summation of item responses into total scores assumes equal intervals between categories. While 
studies have identified problems with rating scale response category functioning there is a paucity of empirical studies 
regarding how respondents interpret response categories. We investigated the interpretation of commonly used 
rating scale response categories and attempted to identify distinct and roughly equally spaced response categories for 
patient-reported rating scales in Parkinson's disease (PD) and age-matched control subjects.
Methods: Twenty-one rating scale response categories representing frequency, intensity and level of agreement were 
presented in random order to 51 people with PD (36 men; mean age, 66 years) and 36 age-matched controls (14 men; 
mean age, 66). Respondents indicated their interpretation of each category on 100-mm visual analog scales (VAS) 
anchored by Never - Always, Not at all - Extremely, and Totally disagree - Completely agree. VAS values were compared 
between groups, and response categories with mean values and non-overlapping 95% CIs corresponding to equally 
spaced locations on the VAS line were sought to identify the best options for three-, four-, five-, and six-category scales.
Results: VAS values did not differ between the PD and control samples (P = 0.286) or according to educational level (P 
= 0.220), age (P = 0.220), self-reported physical functioning (P = 0.501) and mental health (P = 0.238), or (for the PD 
sample) PD duration (P = 0.213) or presence of dyskinesias (P = 0.212). Attempts to identify roughly equally spaced 
response categories for three-, four-, five-, and six-category scales were unsuccessful, as the 95% CIs of one or several of 
the identified response categories failed to include the criterion values for equal distances.
Conclusions: This study offers an evidence base for selecting more interpretable patient-reported rating scale 
response categories. However, problems associated with raw rating scale data, primarily related to their ordinal 
structure also became apparent. This argues for the application of methodologies such as Rasch measurement. Rating 
scale response categories need to be treated with rigour in the construction and analysis of rating scales.
Background
Patient-reported rating scales are gaining increasing
importance in determining patient status and effective-
ness of therapies. In such scales, responses to a number of
items are typically summed to yield a total score intended
to locate the respondent on a continuum from less to
more on the variable of interest. Following the tradition
of Likert [1], this is achieved by assigning integral numer-
als (e.g., 0 - 1 - 2 - 3) to descriptive response categories
(e.g., none - mild - moderate - severe) as a means of parti-
tioning the underlying latent quantitative continuum into
successively increasing (or decreasing) amounts of the
variable.
Although the summed rating scale approach may
appear simple and straight forward, its appropriateness
and legitimacy rests on some fundamental assumptions
that often appear overlooked. First, for respondents to be
able to communicate their positions accurately (and for
investigators and clinicians to accurately interpret those
responses), the descriptive response category labels need
to have distinct and unambiguous meanings that reflect
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differences in amount [2]. Second, for arithmetic opera-
tions, such as summation of integral numerals assigned to
response categories to be performed and interpreted
legitimately, the magnitudes that successive categories
represent need to be equally spaced [3,4]. Recently, these
criteria have been emphasized by the U.S. Food and Drug
Administration (FDA) for patient-reported rating scales
to be considered appropriate as clinical trial endpoints
[5].
Although attention has been paid to these and related
issues in the behavioral and social sciences [2,6-8], less
work appears to have been conducted in the clinical
health sciences [9-11]. Furthermore, a considerable num-
ber of participants in available studies in the health arena
have not suffered from any specific medical conditions
[9-11]. Particularly, there seems to be a lack of this type of
study in the clinical neurosciences. However, studies have
shown that rating scale response categories often do not
function as expected and required among people with
neurological disorders such as Parkinson's disease (PD),
multiple sclerosis and stroke [12-18]. These studies illus-
trate that although a larger number of response catego-
ries generally tend to increase variance and, hence,
correlations and reliability coefficients [6], this is not
always the case and might be at the expense of validity
[6,14,16,17,19]. Consideration of how neurological
respondents interpret rating scale response categories is
therefore warranted in order to provide an evidence base
for their selection when developing and modifying
patient-reported rating scales. Additionally, it is unclear
whether rating scale response category interpretations
differ between people with long-term illnesses and con-
trol subjects, since we have been unable to identify any
controlled studies of this kind. This may be particularly
relevant in chronic unpredictable neurological disorders,
such as PD, that impacts a variety of functions.
The objective of this study was to investigate the inter-
pretation of commonly used rating scale response catego-
ries and to identify distinct and roughly equally spaced
response categories for patient-reported rating scales in
PD and age-matched control subjects.
Methods
Two samples were used: 51 consecutive Swedish speaking
people with neurologist diagnosed PD [20] without clini-
cally significant mental impairments (e.g. dementia, con-
fusion) were recruited from a Swedish university hospital,
and 36 age-matched controls without neurological disor-
ders were recruited through snowball sampling. In addi-
t i o n  t o  a g e ,  i t  w a s  d e s i r e d  t h a t  c o n t r o l s  s h o u l d  h a v e
approximately the same educational background as the
PD sample.
Participants were interviewed regarding demographic
characteristics and self-completed the physical function-
ing and mental health scales of the SF-36 [21,22]. People
with PD were also assessed regarding Hoehn & Yahr
s tag es of  P D seve rit y [ 23 ] .  P a rt ici pan ts w e r e  t he n pr e -
sented with 21 rating scale response options representing
ratings of frequency, intensity and level of agreement (see
Table 1). Respondents indicated their interpretation of
each of the 21 response categories on 100-mm visual ana-
log scales (VAS) anchored by Never - Always (frequency),
Not at all - Extremely (intensity), and Totally disagree -
Completely agree (agreement) [9,10]. Categories and
anchors were taken from patient-reported rating scales
used in PD [22,24-29]. Response categories were pre-
sented one at a time, on separate sheets and in random
order; each sheet consisted of one response category and
a corresponding 100-mm anchored VAS line. Before
commencing this part of the data collection, the investi-
gators ascertained that participants understood the task
by explaining the procedure and its objective. In doing so,
the task was illustrated by an example relating the word
"warm" to a VAS line anchored by "ice cold" and "boiling
hot". During data collection, any comments regarding the
response categories and their interpretation were
recorded. If a respondent was unable to assess the magni-
tude of a response category, this was recorded as a miss-
ing value.
The study was reviewed by the institutional ethics advi-
sory committee and was conducted in accordance with
the Declaration of Helsinki. All participants provided
written informed consent.
Analyses
Statistical analyses were conducted using SPSS 14 for
Windows (SPSS Inc., Chicago IL). P-values were adjusted
for multiple testing using the Benjamini-Hochberg proce-
dure [30], and considered statistically significant when <
0.05. The distribution of data was assessed regarding uni-
variate and multivariate normality (Kolmogorov-Smirnov
and Mardia's tests) and described and analyzed accord-
ingly.
Group comparisons of rating scale response category 
interpretations
Nonparametric multivariate analysis of variance
(MANOVA) [31] was used to compare VAS values from
PD and control respondents. If no significant differences
between groups were identified, the pooled data was used
to explore (using nonparametric MANOVA) whether
VAS values differed according to educational level (uni-
versity/professional degree vs others), age, physical func-
tioning and mental health (with the latter three
dichotomized by their median values). For the PD group,
differences in VAS values according to PD duration
(dichotomized by the median) and whether patients
experienced dyskinesias or not were also explored.Knutsson et al. Health and Quality of Life Outcomes 2010, 8:61
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Identification of distinct rating scale response categories
To determine the best response options for the three
types of ratings, the mean, standard deviations (SD) and
95% confidence intervals (CIs) of the VAS values were
examined [9,10]. The criterion was that mean VAS values
(or their associated 95% CIs) should be distributed
equally across the 0-100 mm continuum, assuming the
values of 0 and 100 for the predefined extreme anchor
categories. This was done for three-, four-, five- and six-
category response scales. For example, for a five-category
response scale, the three response categories with mean
VAS values closest to 25, 50 and 75 mm were identified
and each 95% CI was examined to determine if it covered
the criterion value. For three-, four- and six-category
response scales the corresponding reference locations
were 50 mm (three categories), 33 and 67 mm (four cate-
gories) and 20, 40, 60 and 80 mm (six categories). In addi-
tion to roughly equal distances between mean locations,
the 95% CIs for the VAS values of the selected response
categories should not overlap. If two or more response
categories met these criteria, the one with the smallest
dispersion (SD) was selected. Finally, participants' com-
ments were also taken into account when determining
response category suitability.
Table 1: Descriptive response category VAS data
Mean SD 95% CI Median q1-q3 Min-max
Frequency:
f1 Seldom (sällan) 25.3 16.4 21.8-28.8 20 14-31 3-72
f2 Occasionally (vid enstaka tillfällen) 30.8 20.5 26.4-35.2 24 15-40 4-82
f3 A little of the time (lite av tiden) 33.7 18.0 29.9-37.6 28 21-46 7-75
f4 Some of the time (en del av tiden) 44.7 16.8 41.1-48.3 43.5 33-54.5 15-81
f5 Sometimes (ibland) 45.9 17.5 42.2-49.6 48 33-52 14-91
f6 A good bit of the time (en hel del av tiden) 71.1 18.3 67.2-75 75 67-82 5-98
f7 Often (ofta) 74.7 12.7 72.0-77.4 76 70-83 32-98
f8 Most of the time (största delen av tiden) 76.8 16.3 73.3-80.3 80 71-89 21-99
Intensity:
i1 A little bit (en aning) 21.9 15.2 18.6-25.1 19 11-28 2-76
i2 Slightly (lite) 24.0 14.1 21.0-27 21 14-27 2-78
i3 Somewhat (något) 29.8 17.4 26.1-33.6 26 17-37.5 2-83
i4 Moderately (måttligt) 42.1 14.3 39-45 44 31.8-50.2 6-86
i5 Quite a bit (ganska mycket) 73.5 11.9 71-76.1 74 66-81 38-96
i6 A lot (mycket) 73.7 14.1 70.7-76.6 76 69-82 24-99
Agreement:
a1 Disagree (stämmer inte) 15.5 21.2 11-20 7 2-19 0-81
a2 Mostly false (stämmer inte särskilt bra) 28.0 17.7 24.2-31.8 23 16-34 4-84
a3 Don't know (osäker) 38.9 19.1 34.8-43 40 24-50 2-84
a4 Do not agree or disagree (varken stämmer 
eller stämmer inte)
43.2 16.0 39.8-46.6 49 41-52 0-71
a5 Mostly true (stämmer ganska bra) 70.7 14.7 67.6-73.8 74 63-81 32-94
a6 Agree (stämmer) 78.3 21.9 73.6-83 86 64-95 13-100
a7 Strongly agree (stämmer helt) 86.7 18.2 82.7-90.6 95 82.5-99 22-100
Visual analog scale (VAS) values for the 21 rating scale response categories as determined by people with Parkinson's disease and control subjects. 
Categories are organized in ascending order (from lower to higher mean VAS values). Swedish category wordings used in this study are given in 
parentheses a
a There were two instances of missing VAS data among people with Parkinson's disease (both involving category a7) and six missing VAS values 
among controls, including one each for categories i3 and i4, and three missing values for category a3.
SD, standard deviation; CI, confidence interval; q1-q3, 25th and 75th percentiles.Knutsson et al. Health and Quality of Life Outcomes 2010, 8:61
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Results
Sample characteristics are reported in Table 2. There
were no differences between people with PD and controls
regarding age, educational levels or mental health scores,
but there were more men in the PD sample, and controls
had better physical functioning scores than people with
PD (Table 2). Data collection also took significantly lon-
ger for people with PD (mean [SD], 17.4 [7.2] minutes)
than for controls (mean [SD], 12.7 [4.3] minutes) to com-
plete (P = 0.001; unpaired t-test). In the PD group, 94%
were treated with levodopa, 82% were on dopamine ago-
nists, COMT- and MAO-inhibitors were used among
43% each, and 25% had undergone a neurosurgical inter-
vention for their PD.
Group comparisons of rating scale response 
category interpretations
MANOVA of overall differences among VAS values
between PD and control groups was not significant (P =
0.286). Similarly, MANOVAs of VAS values for the
pooled sample did not display any significant differences
between educational levels (P = 0.220), age groups (P =
0.220), or between people with lower and higher physical
functioning (P = 0.501) and mental health (P = 0.238)
scores. In the PD sample, there were no differences
between people with shorter and longer disease durations
(P = 0.213) or between those with or without dyskinesias
(P = 0.212).
Identification of distinct rating scale response 
categories
Results from the VAS evaluations of the 21 rating scale
response categories from the pooled sample are pre-
sented in Table 1 and Figure 1, with categories organized
in ascending order (from lower to higher mean VAS val-
ues) within each of the three response category types.
Additional file 1 presents the corresponding data sepa-
rately for people with PD and controls.
One third (n = 12) of the control group and 43% (n =
22) of the PD group expressed difficulties interpreting the
response category Don't know. Difficulties were also
expressed by one or two respondents each for the catego-
ries Sometimes, Somewhat, Moderately, and Do not agree
or disagree.
Based on these observations the best three-, four-, five
and six-category response scales according to the pre-
defined criteria are provided in Figure 2. It can be seen
that the equal distances criterion was not fully met in
either of the identified three-, four-, five or six-category
response scales for any of the three types of ratings. The
proportion of categories whose 95% CI covered the crite-
rion VAS values was highest for the six-category agree-
Table 2: Sample characteristics
PD (n = 51) Controls (n = 36) P-value e
Male gender, n (%) 36 (71) 14 (39) 0.008 f
Age, mean (SD) 66 (8.1) 66.2 (9.3) 0.889 g
Academic/professional degree, n (%) 26 (51) 19 (53) 0.889 f
Physical functioning, median (q1-q3) a 75 (50-90) 90 (80-95) 0.008 h
Mental health, median (q1-q3) a 76 (64-88) 84 (76-92) 0.068 h
PD duration (years), mean (SD) 9.8 (5.6) - -
Hoehn & Yahr ("on"), median (q1-q3; 
min-max) b,c
II (II-III; I-V) - -
Hoehn & Yahr ("off"), median (q1-q3; 
min-max) b,d
III (III-IV; I-V) - -
Motor fluctuations, n (%) 36 (71) - -
Dyskiesias, n (%) 25 (49) - -
a According to the Physical Functioning and Mental Health scales of the SF-36. Possible score range, 0-100 (100 = better).
b Range, I-V (I = mild unilateral disease; II = Bilateral disease without postural impairment; III = Bilateral disease with postural impairment, 
moderate disability; IV = Severe disability, still able to walk and stand unassisted; V = Confined to bed or wheelchair unless aided) [23].
c As determined for the "on" phase, i.e. periods with good anti-parkinsonian drug response.
d As determined for the "off" phase, i.e. periods with poor or no anti-parkinsonian drug response.
e Adjusted for multiple testing using the Benjamini-Hochberg procedure [30].
f Chi-square test.
g Independent samples t-test.
h Mann-Whitney U-test.
PD, Parkinson's disease; SD, standard deviation; q1-q3, 25th and 75th percentiles.Knutsson et al. Health and Quality of Life Outcomes 2010, 8:61
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Figure 1 Response category mean VAS values and 95% CIs. Mean values (black dots) with associated 95% confidence intervals (error bars) for 100-
mm visual analog scale (VAS) ratings (y-axis) of the perceived meaning of response category wordings (x-axis) in relation to (A) Never (0 mm) - Always 
(100 mm), (B) Not at all (0 mm) - Extremely (100 mm), and (C) Totally disagree (0 mm) - Completely agree (100 mm) among people with Parkinson's dis-
ease (n = 51) and an age-matched control group (n = 36). See Methods for details.
A
Always
Never
Seldom Occasio-
nally
A little of
the time
Some of
the time
Some-
times
A good bit
of the time
Often Most of
the time
B Extremely
Not at all
A little bit Slightly Somewhat Moderately Quite a bit A lot
C
Completely agree
Totally disagree
Disagree Mostly
false
Don’t know Do not
agree or
disagree
Mostly true Agree Strongly
agreeKnutsson et al. Health and Quality of Life Outcomes 2010, 8:61
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ment scale (75%), followed by the five category scales for
all three types of ratings (67%).
Discussion
This appears to be the first controlled study on the inter-
pretation of patient-reported rating scale response cate-
gories in the clinical neurosciences. As such, it provides a
first evidence base and initial guidance for selection of
rating scale response categories when developing new or
modifying available patient-reported rating scales for PD.
This is highly relevant as clarity, distinctiveness and
equality of response category intervals represent funda-
mental assumptions underpinning traditional rating scale
construction [1,32] that are recognized by, e.g. the FDA
when judging the appropriateness of rating scales as clini-
cal trial endpoints [5]. Although focusing on PD, the lack
of systematic differences between people with PD and
age-matched controls, as well as between other health-
related respondent characteristics, suggests that our find-
ings are relevant beyond this context.
The identified best categories for three-, four-, five and
six-category response scales were not optimal, as they
failed to fulfill the assumption of equal inter-category dis-
tances also when considering their 95% CIs. For example,
the distances between Some of the time and A good bit of
the time are clearly different from those between A good
bit of the time and Most of the time. Extrapolating data
from this study to response categories in commonly used
scales reveals similar problems. For example, the three
non-extreme response options in the original PDQ-39
(Occasionally  -  Sometimes  -  Often) [27] correspond to
mean VAS locations of 30.8, 45.9 and 74.7, respectively.
That is, the estimated distance between the latter two cat-
egories is about twice as large as that between the former
two. Similar or more extreme situations are evident with
scales such as the PFS-16 [24], FACIT-F [29], SF-36 [22],
PDQL [25], and PDQUALIF [28].
Conceivably, this has at least two consequences. First, it
may contribute to respondent difficulties in using the
response options. Second, it is unknown what a certain
difference in raw rating scale scores represents and by
how much more someone has changed compared to peo-
ple with smaller change scores. This illustrates the ordi-
nal nature of raw rating scale data and argues against the
legitimacy of analyzing and interpreting summed integral
numerals from item responses as linear measures
[3,33,34]. This latter aspect represents a fact perhaps
partly overlooked when developing rating scales; that is,
the profound step that is taken when transforming words
(qualitative descriptors) into numbers (quantities) that
typically are treated as linear measures.
Figure 2 Selected response categories. Selected response categories for three-, four-, five-, and six-category response scales as determined from 
observed visual analog scales (VAS) values. See Methods for details.
* 95% CI of category VAS value does not cover criterion value. Arrows indicate direction of discrepancy (￿, below criterion value; T, above criterion 
value); see Table 1 for raw data.
Criteria VAS values (mm):
0 50 100
3 categories Frequency (never) Sometimes *  (always)
Intensity  (not at all) Moderately *  (extremely) 
Agreement (totally disagree) Do not agree or disagree *  (completely agree)
Criteria VAS values (mm):
0  33 67 100
4 categories Frequency (never) A little of the time A good bit of the time *  (always)
Intensity (not at all) Somewhat Quite a bit *  (extremely) 
Agreement (totally disagree) Mostly false *  Mostly true *  (completely agree)
Criteria VAS values (mm):
0 25 50 75 100
5 categories Frequency (never) Seldom Sometimes * Often (always)
Intensity (not at all) Slightly Moderately * Quite  a  bit (extremely) 
Agreement (totally disagree) Mostly false Do not agree or 
disagree * 
Agree (completely agree)
Criteria VAS values (mm):
0  20 40 60 80 100
6 categories Frequency (never) Seldom *  Some of the 
time * 
A good bit of the 
time * 
Most of the time (always)
Intensity (not at all) A little bit Moderately Quite a bit *  A lot *  (extremely) 
Agreement (totally disagree) Disagree Do not agree or 
disagree
Mostly true *  Agree (completely 
agree)Knutsson et al. Health and Quality of Life Outcomes 2010, 8:61
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There are a number of aspects that need to be taken
into consideration when interpreting the results pre-
sented here. First, the appropriateness of using VAS to
evaluate participants' interpretation of response catego-
ries may be questioned since evidence speaks against the
linearity of VAS data [35]. However, there is also evidence
supporting the linearity of VAS ratings [36,37], and the
approach has been found useful in previous studies of rat-
ing scale category interpretations [9-11]. Second, our
observations refer to the Swedish versions of the studied
response categories, and the equivalence between various
language versions is dependent on cultural and semantic
aspects, as well as the quality of the translation. It has for
example been shown that interpretations of the same
response category can differ between languages as well as
between cultures within the same language [11]. How-
ever, the VAS values found here are in general agreement
with those reported in previous studies using the same
methodology and response categories [9,10]. This sug-
gests that our observations are not necessarily limited to
a Swedish context. Third, we limited the types of
response categories to frequency, intensity and agree-
ment, and there are also response categories of these
types that were not covered here. Furthermore, the
anchor categories were assumed to have fixed values at 0
and 100 mm, whereas their interpretations actually may
differ between people. For example, studies investigating
the perceived absolute frequency or probability of occur-
rence associated with frequency descriptors have found
variations in the interpretation of Always as well as Never
[38,39].
The samples studied here were not randomly selected,
which may limit the generalizability of results. Further-
more, the sample sizes were somewhat limited, which
influences the precision of observations and, therefore,
renders the reported 95% CIs wider than otherwise
would have been the case. However, given that data failed
to support the assumption of equal inter-category dis-
tances even with consideration of the observed CIs,
increasing the number of observations would presumably
have yielded even stronger evidence against legitimate
raw score summation of the response categories studied
here. Similarly, the lack of differences between people
with PD and control subjects, as well as between other
subgroups also needs to be interpreted in view of the
sample size. That is, with increasing numbers of observa-
tions, statistically significant differences are increasingly
likely to be detected. However, statistical significance says
nothing about the practical significance of differences,
which is not known for the current type of data.
The variability in interpretations of response categories
was wide between individuals (as illustrated by the ranges
o f  V AS  va l ues) .  T his  does  not  a ppear  t o be  li m it ed t o
patient-reported data, as studies regarding physicians'
interpretation of various probability related expressions
(including some of the response categories studied here)
have shown similar variability [38]. This variability fur-
ther complicates score interpretation at the individual
patient level. An important aspect in this respect is the
extent to which interpretations are stable within individ-
uals over time. This needs to be assessed in further stud-
ies designed for this purpose. Such studies would also
allow for direct evaluation of the error variation in VAS
ratings, which is an important aspect for the interpret-
ability of data that was not considered in this study.
Our observations concern the interpretation of
response categories without reference to a particular con-
text. This is different from the use of response categories
in rating scales where items articulate the context within
which responses are requested. Studies have shown that
the meaning of descriptors of, e.g. frequency differ
according to context as well as respondents' experiences
within the context [32,40]. While this hampers the possi-
bilities to make valid comparisons of raw rating scale data
between people and between scales tapping different
variables, the magnitude of these effects for various
health outcome variables is uncertain and will need to be
addressed in future studies.
A large proportion of respondents expressed difficulties
with the response category Don't know. This observation
is in accordance with previous studies of neutral middle
categories (e.g., Undecided, ?, and Not sure) in Likert type
response scales [19,41,42]. These studies have shown that
there may be a variety of reasons why respondents select
this type of response category and that in practice, it does
not operate as a middle category. It has therefore been
recommended that it should not be presented as an inte-
gral part of a continuum of levels of agreement but, if
u s e d  a t  a l l ,  b e  p r e s e n t e d  s e p a r a t e l y  f r o m  c a t e g o r i e s
expressing agreement levels [41]. The observations
reported here provide further qualitative evidence in sup-
port for this notion.
The ordinal nature of rating scale response categories
challenges the legitimacy of summing individual item
scores into total scores, as well as their interpretability
[3,4,34]. However, there are means to empirically deter-
mine how the response categories used with a particular
set of items function when administered to a particular
group of people, and to overcome the assumption of
equal intervals in the construction of total scores. Specifi-
cally, the polytomous Rasch measurement model for
ordered response categories does not assume equal inter-
vals between response categories, tests whether thresh-
olds between adjacent categories are ordered in the
expected manner, and provides a means of exploring the
effect of collapsing adjacent categories [19,41,43,44].
Additionally, the Rasch model defines, mathematically,
the requirements that data need to meet in order to pro-Knutsson et al. Health and Quality of Life Outcomes 2010, 8:61
http://www.hqlo.com/content/8/1/61
Page 8 of 9
duce measurements, and when these requirements are
met scores can be expressed as invariant measures
instead of ordinal numbers [33,45-47]. This study argues
for a wider application of this methodology, including
appropriate appreciation of response category function-
ing, whenever rating scale data are used for measure-
ment. For purposes of assessment (in contrast to
measurement [33,46,48]) an alternative to summed total
scores that takes the ordinal nature of rating scale
response categories into consideration would, e.g., be the
approaches proposed by Svensson [49].
Conclusions
Although in need of replication and extension, this study
offers an evidence base for selecting more interpretable
patient-reported rating scale response categories. As
such, it provides guidance when developing new or modi-
fying existing rating scales. However, it must be stressed
that the selection of response categories also should be
guided by additional considerations, so that they express
levels of the construct articulated by the items in a mean-
ingful way that is congruent with the intention of the
scale. In this perspective, response categories alternative
to those primarily identified here may be appropriate,
particularly since the difference between identified and
alternative categories in some cases were marginal. Our
observations also illustrate problems associated with raw
rating scale data that clinicians and investigators need to
be aware of and that argue for the application of newer
rating scale methodologies such as Rasch measurement.
Response categories need to be treated with rigour in the
construction and application of rating scales.
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